Horizon Analytical is real and independently verifiable — we tested its own portal ourselves and got a reproducible historical match. Not accredited, no public address, several safety-relevant panels remain unbuilt, and new reporting ties it operationally to Aspire Labs (which also owns vendor Direct Peptides) in a way that sits uneasily with Horizon's own independence claim for that specific relationship: a legitimate mid-tier verification with a real open question, not a full safety guarantee.
Horizon Analytical is a research-compound testing lab offering UPLC/MS purity and identity testing, with per-lot COAs searchable through a public verification portal. Offers standard peptide, peptide blend, and GLP-1-specific HPLC/MS panels, plus LAL endotoxin testing.
Horizon Analytical does not claim ISO/IEC 17025 accreditation anywhere on its own site, and no listing was found in the A2LA registry.
The Verify COA portal (horizonanalytical.com/verify-coa) is live and fully functional — tested directly with a real historical lot number (TRL-9907743) from a True Research Labs COA and it correctly returned both matching records (compound: Selank), reproducing the original finding exactly. Endotoxin (LAL) testing is now a live paid offering ($175, 5–7 days) — a real capability added since this lab was first reviewed.
No physical address is published anywhere on the site. Direct A2LA registry search did not complete cleanly during this session (technical error on A2LA's own search interface) — absence of accreditation is inferred from the lab's own site making no such claim, not from a confirmed registry search.
Heavy Metals and Sterility panels are both still listed as "Coming Soon," and a third gap not previously noted — "Proteins & HGH" testing — is also marked "Coming Soon." For an injectable research compound, this means Horizon currently covers identity/purity/potency and endotoxin, but not a full safety panel. New as of 2026-11-03: independent investigative reporting (a two-part deep-dive, partially corroborated by a USPTO trademark filing) found Horizon is operationally tied to Aspire Labs, which also owns Direct Peptides — a vendor whose COAs come through Horizon. Reporting describes Aspire's own recruiting materials as crediting Aspire with "building Horizon Analytical's laboratory operation," and Direct Peptides COAs as provided "at cost" with "no profit to Horizon built in." This sits in tension with Horizon's own compliance policy, which states it is "independent of Direct Peptides" and that "Direct Peptides and other customers do not control Horizon's methods, quality review, results, or reporting." We have not independently confirmed the ownership structure beyond this secondary reporting, and it's unclear whether or how this affects Horizon's testing for its OTHER clients (e.g. True Research Labs, whose COA we independently reproduced) — flagged as a real, specific conflict-of-interest concern for the Direct Peptides relationship specifically, not resolved into a tier change here pending a closer look.
Verify a COA from Horizon Analytical yourself: horizonanalytical.com/verify-coa — tested directly by Watchtower and confirmed working.
Last reviewed November 3, 2026 by Watchtower Peptides.